Upper GI Bleeding - Causes, Treatment & When to See a Doctor

```html

What is Upper GI Bleeding?

Upper gastrointestinal (GI) bleeding refers to any bleeding that originates proximal to the ligament of Treitz, which separates the duodenum (the first part of the small intestine) from the jejunum. In practical terms, the source is usually the esophagus, stomach, or the first portion of the duodenum. The blood may be visible in the vomit (hematemesis), mixed with saliva, or it may be digested and appear as black, tarry stools (melena). Although many episodes are self‑limited, upper GI bleeding can become a medical emergency requiring prompt evaluation and treatment.

According to the Mayo Clinic, upper GI bleeds account for roughly 80% of all GI hemorrhages and are a leading cause of hospital admission for gastrointestinal disorders.

Common Causes

There are many conditions that can damage the lining of the upper GI tract and lead to bleeding. The most frequent culprits include:

• Peptic ulcer disease (PUD): Erosions caused by Helicobacter pylori infection or chronic NSAID use.
• Gastric erosions & gastritis: Inflammation of the stomach lining, often related to alcohol, stress, or infection.
• Esophageal varices: Dilated veins in the esophagus secondary to portal hypertension, commonly seen in cirrhosis.
• Mallory‑Weiss tear: A longitudinal mucosal laceration at the gastro‑esophageal junction after forceful vomiting or retching.
• Esophagitis: Inflammation from gastro‑esophageal reflux disease (GERD) or chemical injury (e.g., ingestion of caustic substances).
• Dieulafoy lesion: An abnormally large submucosal artery that erodes the overlying mucosa.
• Gastric cancer: Malignancies can ulcerate and bleed.
• Angiodysplasia: Vascular malformations, more common in the duodenum than the colon.
• Stress‑related mucosal disease: Critically ill patients (e.g., in ICU) may develop “stress ulcers.”
• Drug‑induced injury: Anticoagulants, antiplatelet agents, and selective serotonin reuptake inhibitors (SSRIs) can increase bleeding risk when combined with mucosal damage.

Associated Symptoms

Upper GI bleeding rarely occurs in isolation. Patients often notice other clues that point to the source or severity of the bleed:

• Vomiting of bright red blood (hematemesis) or coffee‑ground–appearing material.
• Black, tarry stools (melena) – indicates digested blood.
• Abdominal pain or discomfort, especially epigastric pain in ulcer disease.
• Feeling light‑headed, dizzy, or faint – signs of volume depletion.
• Rapid heartbeat (tachycardia) and low blood pressure (hypotension).
• Fever or chills if the bleed is associated with infection (e.g., perforated ulcer).
• Weight loss or early satiety in chronic conditions such as gastric cancer.

When to See a Doctor

Because upper GI bleeding can progress quickly, it is essential to seek medical care promptly if you notice any of the following:

• Vomiting blood, whether bright red or looking like coffee grounds.
• Black, tarry stools or any change in stool color that lasts more than 24 hours.
• Severe or worsening abdominal pain.
• Dizziness, fainting, or an inability to stay upright.
• Rapid heartbeat, low blood pressure, or a sudden drop in energy.
• Any bleeding while taking blood thinners or antiplatelet medication.

Even if the bleed seems mild, a physician should evaluate the cause to prevent recurrence and rule out serious pathology.

Diagnosis

Evaluating an upper GI bleed involves a combination of history, physical examination, laboratory tests, and imaging studies.

Initial Assessment

• Vital signs: Blood pressure, heart rate, respiratory rate, and oxygen saturation to gauge hemodynamic stability.
• Physical exam: Look for signs of anemia (pallor), abdominal tenderness, and the presence of melena on rectal exam.

Laboratory Tests

• Complete blood count (CBC) – assesses hemoglobin/hematocrit and platelet count.
• Basic metabolic panel – evaluates kidney function and electrolytes.
• Coagulation profile (PT/INR, aPTT) – especially important if the patient is on anticoagulants.
• Type and screen – prepares for possible blood transfusion.

Endoscopic Evaluation

The gold‑standard diagnostic tool is an esophagogastroduodenoscopy (EGD). Within 24 hours of presentation, an endoscope visualizes the esophagus, stomach, and duodenum, identifies the bleeding source, and often provides immediate therapy (e.g., clipping, cauterization, injection of epinephrine).

Imaging (if endoscopy is not possible)

• Contrast‑enhanced CT angiography – can locate active arterial bleeding.
• Radionuclide bleeding scan (technetium‑99m labeled RBC scan) – detects slower bleeding rates.

Additional Tests

If a variceal bleed is suspected, a transient elastography or liver ultrasound may be ordered to assess underlying liver disease.

Treatment Options

Treatment aims to stabilize the patient, stop the bleeding, and address the underlying cause.

Initial Stabilization

• Airway, Breathing, Circulation (ABCs): Provide supplemental oxygen if needed; secure airway for massive hematemesis.
• Intravenous fluids: Crystalloid bolus (e.g., normal saline) to maintain blood pressure.
• Blood transfusion: Target hemoglobin 7–9 g/dL in most patients; higher thresholds for cardiovascular disease.
• Medications:
  • Proton pump inhibitors (PPIs) – high‑dose IV omeprazole or pantoprazole to reduce gastric acidity and promote clot stability.
  • Octreotide – for suspected variceal bleeding; decreases portal pressure.
  • Tranexamic acid – may be considered in selected cases, although evidence is mixed.

Endoscopic Therapy

During EGD, the endoscopist can:

• Inject epinephrine around the bleeding point.
• Apply thermal cautery (heater probe, bipolar coagulation).
• Place clips or bands (especially for varices).
• Use hemostatic powders (e.g., Hemospray) for diffuse oozing.

Radiologic & Surgical Interventions

• Trans‑arterial embolization (TAE): Interventional radiology can occlude bleeding vessels when endoscopy fails.
• Surgery: Reserved for uncontrolled bleeding, perforation, or when a tumor is the source. Options include oversewing ulcers, resection of tumors, or shunt procedures for varices.

Long‑Term Management

• Eradicate H. pylori: Triple therapy (PPI + clarithromycin + amoxicillin/metronidazole) for 10–14 days.
• Discontinue or adjust NSAIDs/anticoagulants: Switch to safer alternatives when possible.
• Maintain acid suppression: Oral PPIs for 4–8 weeks after ulcer bleeding, then step‑down based on risk.
• Screen for liver disease: Endoscopic variceal ligation (EVL) or beta‑blockers for portal hypertension.

Prevention Tips

Many causes of upper GI bleeding are modifiable. Consider the following strategies to lower your risk:

• Limit alcohol intake – excess consumption increases gastritis and variceal pressure.
• Avoid smoking – it impairs mucosal defense and promotes ulcer formation.
• Use NSAIDs sparingly; prefer acetaminophen for mild pain, or take NSAIDs with a proton pump inhibitor.
• Take prescribed anticoagulants exactly as directed; have regular INR checks if on warfarin.
• Screen and treat Helicobacter pylori infection, especially before long‑term NSAID therapy.
• Maintain a healthy weight and diet rich in fruits, vegetables, and fiber; reduce spicy or highly acidic foods if they trigger reflux.
• Manage chronic diseases (e.g., liver cirrhosis, heart failure) with your healthcare team to lower portal hypertension.
• Stay up‑to‑date on vaccinations (e.g., hepatitis B) that can prevent liver disease and subsequent varices.

Emergency Warning Signs

Key Take‑aways

Upper GI bleeding is a potentially serious condition that usually stems from ulcer disease, varices, or mucosal injury. Prompt recognition, early endoscopic evaluation, and targeted therapy dramatically improve outcomes. While some risk factors (age, genetics) cannot be changed, lifestyle modifications, appropriate medication use, and treatment of underlying infections or liver disease can markedly lower the chance of a future bleed. When in doubt, seek medical attention promptly; early intervention can be lifesaving.

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, Gastroenterology journal (2022); American College of Gastroenterology guidelines (2023).

```